Capex / revenue moved 250326 bp higher
Capex / revenue changed +250326 basis points from the comparable as-filed period.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Capex / revenue changed +250326 basis points from the comparable as-filed period.
Capital expenditure changed +836.2% from the comparable as-filed period.
Gross margin changed -372 basis points from the comparable as-filed period.
Gross profit changed -76.6% from the comparable as-filed period.
Operating income changed +65.6% from the comparable as-filed period.
Operating margin changed +162813 basis points from the comparable as-filed period.
Revenue changed -67.2% from the comparable as-filed period.
Stock-based compensation changed -44.0% from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.